74 related articles for article (PubMed ID: 15862966)
21. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
22. Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen.
Coutinho-Camillo CM; Salaorni S; Sarkis AS; Nagai MA
Cancer Genet Cytogenet; 2006 Apr; 166(2):130-8. PubMed ID: 16631469
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of tumor necrosis factor-induced necrotic cell death by the zinc finger protein A20.
Heyninck K; Denecker G; De Valck D; Fiers W; Beyaert R
Anticancer Res; 1999; 19(4B):2863-8. PubMed ID: 10652565
[TBL] [Abstract][Full Text] [Related]
24. The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells.
Ulrix W; Swinnen JV; Heyns W; Verhoeven G
FEBS Lett; 1999 Jul; 455(1-2):23-6. PubMed ID: 10428464
[TBL] [Abstract][Full Text] [Related]
25. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
[TBL] [Abstract][Full Text] [Related]
26. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
28. Calcitriol inhibits growth response to Platelet-Derived Growth Factor-BB in human prostate cells.
Nazarova N; Golovko O; Bläuer M; Tuohimaa P
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):189-96. PubMed ID: 15862965
[TBL] [Abstract][Full Text] [Related]
29. Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer.
Sidiropoulos M; Chang A; Jung K; Diamandis EP
Br J Cancer; 2001 Aug; 85(3):393-7. PubMed ID: 11487271
[TBL] [Abstract][Full Text] [Related]
30. Androgen regulation of the human pseudoautosomal gene MIC2, a potential marker for prostate cancer.
Shen J; Zhau HE; Hursting SD; Chung LW
Mol Carcinog; 1998 Sep; 23(1):13-9. PubMed ID: 9766433
[TBL] [Abstract][Full Text] [Related]
31. Calcitriol-induced prostate-derived factor: autocrine control of prostate cancer cell growth.
Nazarova N; Qiao S; Golovko O; Lou YR; Tuohimaa P
Int J Cancer; 2004 Dec; 112(6):951-8. PubMed ID: 15386353
[TBL] [Abstract][Full Text] [Related]
32. Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3.
Murthy S; Marcelli M; Weigel NL
Prostate; 2003 Sep; 56(4):293-304. PubMed ID: 12858358
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
35. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
Asirvatham AJ; Schmidt MA; Chaudhary J
Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
[TBL] [Abstract][Full Text] [Related]
36. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas.
Chang GT; Blok LJ; Steenbeek M; Veldscholte J; van Weerden WM; van Steenbrugge GJ; Brinkmann AO
Cancer Res; 1997 Sep; 57(18):4075-81. PubMed ID: 9307296
[TBL] [Abstract][Full Text] [Related]
37. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line.
Henttu P; Liao SS; Vihko P
Endocrinology; 1992 Feb; 130(2):766-72. PubMed ID: 1370795
[TBL] [Abstract][Full Text] [Related]
38. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
39. The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells.
Geier R; Adler S; Rashid G; Klein A
Prostate; 2010 Sep; 70(12):1307-12. PubMed ID: 20623632
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
Bao BY; Ting HJ; Hsu JW; Yasmin-Karim S; Messing E; Lee YF
J Steroid Biochem Mol Biol; 2010 May; 120(1):11-21. PubMed ID: 20206692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]